| Year |
Citation |
Score |
| 2020 |
Francis MM, Hummer TA, Liffick E, Vohs JL, Mehdiyoun NF, Visco AC, Yang Z, Kovacs RJ, Zhang Y, Breier A. Effects of fingolimod, a sphingosine-1-phosphate (S1P) receptor agonist, on white matter microstructure, cognition and symptoms in schizophrenia. Brain Imaging and Behavior. PMID 32893328 DOI: 10.1007/S11682-020-00375-7 |
0.302 |
|
| 2019 |
Breier A, Hummer T, Vohs J, Mehdyoun N, Liffick E, Francis M. O12.3. EFFECTS OF FINGOLIMOD, A POTENT ANTI-INFLAMMATORY AGENT, ON BRAIN STRUCTURE, FUNCTION, AND SYMPTOMS IN SCHIZOPHRENIA Schizophrenia Bulletin. 45: S198-S198. DOI: 10.1093/Schbul/Sbz021.267 |
0.338 |
|
| 2018 |
Breier A, Liffick E, Hummer TA, Vohs JL, Yang Z, Mehdiyoun NF, Visco AC, Metzler E, Zhang Y, Francis MM. Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders. Schizophrenia Research. PMID 29588126 DOI: 10.1016/J.Schres.2018.03.012 |
0.303 |
|
| 2017 |
Schnakenberg Martin AM, Bartolomeo L, Howell J, Hetrick WP, Bolbecker AR, Breier A, Kidd G, O'Donnell BF. Auditory feature perception and auditory hallucinatory experiences in schizophrenia spectrum disorder. European Archives of Psychiatry and Clinical Neuroscience. PMID 28936548 DOI: 10.1007/s00406-017-0839-1 |
0.32 |
|
| 2016 |
Hummer TA, Francis MM, Vohs JL, Liffick E, Mehdiyoun NF, Breier A. Characterization of white matter abnormalities in early-stage schizophrenia. Early Intervention in Psychiatry. PMID 27621217 DOI: 10.1111/Eip.12359 |
0.367 |
|
| 2016 |
Minor KS, Marggraf MP, Davis BJ, Mehdiyoun NF, Breier A. Affective Systems Induce Formal Thought Disorder in Early-Stage Psychosis. Journal of Abnormal Psychology. PMID 26999283 DOI: 10.1037/abn0000156 |
0.316 |
|
| 2015 |
Francis MM, Hummer TA, Vohs JL, Yung MG, Liffick E, Mehdiyoun NF, Radnovich AJ, McDonald BC, Saykin AJ, Breier A. Functional neuroanatomical correlates of episodic memory impairment in early phase psychosis. Brain Imaging and Behavior. PMID 25749917 DOI: 10.1007/S11682-015-9357-9 |
0.395 |
|
| 2010 |
Liffick E, Breier A. Pharmacotherapy of first-episode schizophrenia Psychopharm Review. 45: 41-48. |
0.301 |
|
| 2007 |
Breier A, Alphs L, Binneman B. Wayne Fenton's impact on industry. Schizophrenia Bulletin. 33: 1154-5. PMID 17562696 DOI: 10.1093/schbul/sbm068 |
0.32 |
|
| 2006 |
McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, Hawkins KA, Hoffman RE, Preda A, Epstein I, Addington D, Lindborg S, Trzaskoma Q, Tohen M, Breier A. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. The American Journal of Psychiatry. 163: 790-9. PMID 16648318 DOI: 10.1176/Ajp.2006.163.5.790 |
0.376 |
|
| 2005 |
Breier A. Developing drugs for cognitive impairment in schizophrenia. Schizophrenia Bulletin. 31: 816-22. PMID 16150959 DOI: 10.1093/schbul/sbi051 |
0.343 |
|
| 2005 |
Haro JM, Edgell ET, Novick D, Alonso J, Kennedy L, Jones PB, Ratcliffe M, Breier A. Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study. Acta Psychiatrica Scandinavica. 111: 220-31. PMID 15701107 DOI: 10.1111/j.1600-0447.2004.00450.x |
0.302 |
|
| 2004 |
Mitropoulou V, Goodman M, Sevy S, Elman I, New AS, Iskander EG, Silverman JM, Breier A, Siever LJ. Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder. Schizophrenia Research. 70: 27-31. PMID 15246460 DOI: 10.1016/j.schres.2003.10.008 |
0.635 |
|
| 2004 |
Elman I, Rott D, Green AI, Langleben DD, Lukas SE, Goldstein DS, Breier A. Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophrenia. Psychopharmacology. 176: 369-75. PMID 15179540 DOI: 10.1007/S00213-004-1890-Y |
0.607 |
|
| 2004 |
Bitter I, Dossenbach MR, Brook S, Feldman PD, Metcalfe S, Gagiano CA, Füredi J, Bartko G, Janka Z, Banki CM, Kovacs G, Breier A. Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 173-80. PMID 14687871 DOI: 10.1016/J.Pnpbp.2003.09.033 |
0.314 |
|
| 2003 |
Elman I, Lukas S, Shoaf SE, Rott D, Adler C, Breier A. Effects of acute metabolic stress on the peripheral vasopressinergic system in schizophrenia. Journal of Psychopharmacology (Oxford, England). 17: 317-23. PMID 14513924 DOI: 10.1177/02698811030173014 |
0.641 |
|
| 2002 |
Elman I, Goldstein DS, Green AI, Eisenhofer G, Folio CJ, Holmes CS, Pickar D, Breier A. Effects of risperidone on the peripheral noradrenegic system in patients with schizophrenia: a comparison with clozapine and placebo. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 293-300. PMID 12093603 DOI: 10.1016/S0893-133X(02)00314-7 |
0.6 |
|
| 2002 |
Adler CM, Malhotra AK, Elman I, Pickar D, Breier A. Amphetamine-induced dopamine release and post-synaptic specific binding in patients with mild tardive dyskinesia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 295-300. PMID 11850144 DOI: 10.1016/S0893-133X(01)00309-8 |
0.547 |
|
| 2002 |
Tohen M, Chengappa KN, Suppes T, Zarate CA, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Archives of General Psychiatry. 59: 62-9. PMID 11779284 DOI: 10.1001/Archpsyc.59.1.62 |
0.331 |
|
| 2001 |
Wright P, Birkett M, David SR, Meehan K, Ferchland I, Alaka KJ, Saunders JC, Krueger J, Bradley P, San L, Bernardo M, Reinstein M, Breier A. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. The American Journal of Psychiatry. 158: 1149-51. PMID 11431240 DOI: 10.1176/appi.ajp.158.7.1149 |
0.32 |
|
| 2001 |
Elman I, Goldstein DS, Adler CM, Shoaf SE, Breier A. Inverse relationship between plasma epinephrine and testosterone levels during acute glucoprivation in healthy men. Life Sciences. 68: 1889-98. PMID 11292066 DOI: 10.1016/S0024-3205(01)00982-1 |
0.551 |
|
| 2000 |
Breier A, Buchanan RW, Irish D, Carpenter WT. Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. 1993. Psychiatric Services (Washington, D.C.). 51: 1249-53. PMID 11013322 DOI: 10.1176/Appi.Ps.51.10.1249 |
0.361 |
|
| 2000 |
Carpenter WT, Breier A, Buchanan RW, Kirkpatrick B, Shepard P, Weiner E. Mazindol treatment of negative symptoms. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 365-74. PMID 10989263 DOI: 10.1016/S0893-133X(00)00115-9 |
0.402 |
|
| 2000 |
Adler CM, Elman I, Weisenfeld N, Kestler L, Pickar D, Breier A. Effects of acute metabolic stress on striatal dopamine release in healthy volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 545-50. PMID 10731630 DOI: 10.1016/S0920-9964(00)90629-7 |
0.558 |
|
| 2000 |
Elman I, Goldstein D, Adler C, Breier A. Effects of risperidone on catecholaminergic function in patients with schizophrenia Schizophrenia Research. 41: 201. DOI: 10.1016/S0920-9964(00)90797-7 |
0.61 |
|
| 2000 |
Elman I, Goldstein D, Adler C, Breier A. 179. Mechanism of peripheral noradrenergic stimulation by risperidone Biological Psychiatry. 47: S54. DOI: 10.1016/S0006-3223(00)00441-8 |
0.469 |
|
| 1999 |
Adler CM, Malhotra AK, Elman I, Goldberg T, Egan M, Pickar D, Breier A. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. The American Journal of Psychiatry. 156: 1646-9. PMID 10518181 DOI: 10.1176/Ajp.156.10.1646 |
0.644 |
|
| 1999 |
Breier A, Berg PH. The psychosis of schizophrenia: prevalence, response to atypical antipsychotics, and prediction of outcome. Biological Psychiatry. 46: 361-4. PMID 10435201 DOI: 10.1016/S0006-3223(99)00040-2 |
0.334 |
|
| 1999 |
Breier A. Cognitive deficit in schizophrenia and its neurochemical basis. The British Journal of Psychiatry. Supplement. 16-8. PMID 10211135 DOI: 10.1192/S0007125000293604 |
0.376 |
|
| 1999 |
Breier A, Su TP, Malhotra AK, Elman I, Adler CM, Weisenfeld NI, Pickar D. Effects of atypical antipsychotic drug treatment on amphetamine-induced striatal dopamine release in patients with psychotic disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 20: 340-5. PMID 10088134 DOI: 10.1016/S0893-133X(98)00126-2 |
0.571 |
|
| 1999 |
Breier AF, Malhotra AK, Su TP, Pinals DA, Elman I, Adler CM, Lafargue RT, Clifton A, Pickar D. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response. The American Journal of Psychiatry. 156: 294-8. PMID 9989566 DOI: 10.1176/Ajp.156.2.294 |
0.614 |
|
| 1999 |
Elman I, Goldstein DS, Eisenhofer G, Folio J, Malhotra AK, Adler CM, Pickar D, Breier A. Mechanism of peripheral noradrenergic stimulation by clozapine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 20: 29-34. PMID 9885782 DOI: 10.1016/S0893-133X(98)00047-5 |
0.605 |
|
| 1999 |
Elman I, Sokoloff L, Adler CM, Weisenfeld N, Breier A. The effects of pharmacological doses of 2-deoxyglucose on cerebral blood flow in healthy volunteers. Brain Research. 815: 243-9. PMID 9878763 DOI: 10.1016/S0006-8993(98)01137-8 |
0.549 |
|
| 1998 |
Malhotra AK, Breier A, Goldman D, Picken L, Pickar D. The apolipoprotein E epsilon 4 allele is associated with blunting of ketamine-induced psychosis in schizophrenia. A preliminary report. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 19: 445-8. PMID 9778666 DOI: 10.1016/S0893-133X(98)00031-1 |
0.428 |
|
| 1998 |
Breier A, Kestler L, Adler C, Elman I, Wiesenfeld N, Malhotra A, Pickar D. Dopamine D2 receptor density and personal detachment in healthy subjects. The American Journal of Psychiatry. 155: 1440-2. PMID 9766779 DOI: 10.1176/Ajp.155.10.1440 |
0.539 |
|
| 1998 |
Malhotra AK, Goldman D, Mazzanti C, Clifton A, Breier A, Pickar D. A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics. Molecular Psychiatry. 3: 328-32. PMID 9702741 DOI: 10.1038/Sj.Mp.4000412 |
0.395 |
|
| 1998 |
Elman I, Adler CM, Malhotra AK, Bir C, Pickar D, Breier A. Effect of acute metabolic stress on pituitary-adrenal axis activation in patients with schizophrenia. The American Journal of Psychiatry. 155: 979-81. PMID 9659871 DOI: 10.1176/Ajp.155.7.979 |
0.661 |
|
| 1998 |
Breier A, Adler CM, Weisenfeld N, Su TP, Elman I, Picken L, Malhotra AK, Pickar D. Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach. Synapse (New York, N.Y.). 29: 142-7. PMID 9593104 DOI: 10.1002/(Sici)1098-2396(199806)29:2<142::Aid-Syn5>3.0.Co;2-7 |
0.604 |
|
| 1998 |
Bertolino A, Callicott JH, Elman I, Mattay VS, Tedeschi G, Frank JA, Breier A, Weinberger DR. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biological Psychiatry. 43: 641-8. PMID 9582997 DOI: 10.1016/S0006-3223(97)00555-6 |
0.605 |
|
| 1998 |
Pinals DA, Malhotra AK, Breier A, Pickar D. Informed consent in schizophrenia research. Psychiatric Services (Washington, D.C.). 49: 244. PMID 9575016 DOI: 10.1176/Ps.49.2.244 |
0.363 |
|
| 1998 |
Malhotra AK, Goldman D, Buchanan RW, Rooney W, Clifton A, Kosmidis MH, Breier A, Pickar D. The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response. Molecular Psychiatry. 3: 72-5. PMID 9491816 DOI: 10.1038/Sj.Mp.4000288 |
0.43 |
|
| 1998 |
Breier A, Elman I, Goldstein DS. Norepinephrine and schizophrenia: a new hypothesis for antipsychotic drug action. Advances in Pharmacology (San Diego, Calif.). 42: 785-8. PMID 9328015 DOI: 10.1016/S1054-3589(08)60864-9 |
0.587 |
|
| 1998 |
Elman I, Adler CM, Malhotra AK, Bir C, Pickar D, Breier A. Effect of Acute Metabolic Stress on Pituitary-Adrenal Axis Activation in Patients With Schizophrenia American Journal of Psychiatry. 155: 979-981. DOI: 10.1176/ajp.155.7.979 |
0.306 |
|
| 1998 |
Elman I, Goldstein D, Holmes C, Pickar D, Folio J, Adler C, Breier A. Mechanism of peripheral noradrenergic stimulation by clozapine Schizophrenia Research. 29: 143. DOI: 10.1016/S0920-9964(97)88661-6 |
0.479 |
|
| 1998 |
Adler C, Malhota A, Goldberg T, Elman I, Pickar D, Breier A. 278. A comparison of ketamine-induced and schizophrenic thought disorder Biological Psychiatry. 43: S83-S84. DOI: 10.1016/S0006-3223(98)90726-0 |
0.519 |
|
| 1997 |
Elman I, Breier A. Effects of acute metabolic stress on plasma progesterone and testosterone in male subjects: relationship to pituitary-adrenocortical axis activation. Life Sciences. 61: 1705-12. PMID 9363986 DOI: 10.1016/S0024-3205(97)00776-5 |
0.576 |
|
| 1997 |
Kirkpatrick B, Litman D, Kim JW, Vladar K, Breier A, Buchanan RW. Failure of fusion of the septum pellucidum and the heterogeneity of schizophrenia. The Journal of Nervous and Mental Disease. 185: 639-41. PMID 9345255 DOI: 10.1097/00005053-199710000-00008 |
0.377 |
|
| 1997 |
Su TP, Malhotra AK, Hadd K, Breier A, Pickar D. D2 dopamine receptor occupancy: a crossover comparison of risperidone with clozapine therapy in schizophrenic patients. Archives of General Psychiatry. 54: 972-3. PMID 9337781 DOI: 10.1001/Archpsyc.1997.01830220102017 |
0.348 |
|
| 1997 |
Malhotra AK, Adler CM, Kennison SD, Elman I, Pickar D, Breier A. Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine. Biological Psychiatry. 42: 664-8. PMID 9325559 DOI: 10.1016/S0006-3223(96)00546-X |
0.612 |
|
| 1997 |
Pickar D, Malhotra AK, Rooney W, Breier A, Goldman D. Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia. Lancet. 350: 930-1. PMID 9314875 DOI: 10.1016/S0140-6736(05)63266-7 |
0.378 |
|
| 1997 |
Endres CJ, Kolachana BS, Saunders RC, Su T, Weinberger D, Breier A, Eckelman WC, Carson RE. Kinetic modeling of [11C]raclopride: combined PET-microdialysis studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 932-42. PMID 9307606 DOI: 10.1097/00004647-199709000-00002 |
0.303 |
|
| 1997 |
Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D, Breier A. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 17: 141-50. PMID 9272481 DOI: 10.1016/S0893-133X(97)00036-5 |
0.596 |
|
| 1997 |
Breier A, Malhotra AK, Pinals DA, Weisenfeld NI, Pickar D. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. The American Journal of Psychiatry. 154: 805-11. PMID 9167508 DOI: 10.1176/Ajp.154.6.805 |
0.363 |
|
| 1997 |
Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proceedings of the National Academy of Sciences of the United States of America. 94: 2569-74. PMID 9122236 DOI: 10.1073/Pnas.94.6.2569 |
0.389 |
|
| 1997 |
Waltrip RW, Buchanan RW, Carpenter WT, Kirkpatrick B, Summerfelt A, Breier A, Rubin SA, Carbone KM. Borna disease virus antibodies and the deficit syndrome of schizophrenia. Schizophrenia Research. 23: 253-7. PMID 9075304 DOI: 10.1016/S0920-9964(96)00114-4 |
0.367 |
|
| 1997 |
Buchanan RW, Strauss ME, Breier A, Kirkpatrick B, Carpenter WT. Attentional impairments in deficit and nondeficit forms of schizophrenia. The American Journal of Psychiatry. 154: 363-70. PMID 9054784 DOI: 10.1176/Ajp.154.3.363 |
0.335 |
|
| 1997 |
Elman I, Goldstein DS, Holmes C, Adler C, Pickar D, Breier A. The Effects of clozapine on plasma norepinephrine kinetics in schizophrenic patients Schizophrenia Research. 24: 214. DOI: 10.1016/S0920-9964(97)82612-6 |
0.556 |
|
| 1997 |
Breier A, Su T, Saunders R, Carson R, Kolachana B, Weisenfeld N, Malhotra A, Elman I, Eckelmen W, Pickar D. Assessment of synaptic dopamine concentrations in schizophrenia with pet Schizophrenia Research. 24: 176. DOI: 10.1016/S0920-9964(97)82506-6 |
0.575 |
|
| 1996 |
Pinals DA, Malhotra AK, Missar CD, Pickar D, Breier A. Lack of gender differences in neuroleptic response in patients with schizophrenia. Schizophrenia Research. 22: 215-22. PMID 9000318 DOI: 10.1016/S0920-9964(96)00067-9 |
0.378 |
|
| 1996 |
Buchanan RW, Kirkpatrick B, Bryant N, Ball P, Breier A. Fluoxetine augmentation of clozapine treatment in patients with schizophrenia. The American Journal of Psychiatry. 153: 1625-7. PMID 8942462 DOI: 10.1176/Ajp.153.12.1625 |
0.404 |
|
| 1996 |
Malhotra AK, Goldman D, Ozaki N, Rooney W, Clifton A, Buchanan RW, Breier A, Pickar D. Clozapine response and the 5HT2C Cys23Ser polymorphism. Neuroreport. 7: 2100-2. PMID 8930967 DOI: 10.1097/00001756-199609020-00007 |
0.337 |
|
| 1996 |
Frazier JA, Giedd JN, Hamburger SD, Albus KE, Kaysen D, Vaituzis AC, Rajapakse JC, Lenane MC, McKenna K, Jacobsen LK, Gordon CT, Breier A, Rapoport JL. Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia. Archives of General Psychiatry. 53: 617-24. PMID 8660128 DOI: 10.1001/Archpsyc.1996.01830070065010 |
0.391 |
|
| 1996 |
Frazier JA, Giedd JN, Kaysen D, Albus K, Hamburger S, Alaghband-Rad J, Lenane MC, McKenna K, Breier A, Rapoport JL. Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment. The American Journal of Psychiatry. 153: 564-6. PMID 8599409 DOI: 10.1176/Ajp.153.4.564 |
0.403 |
|
| 1996 |
Elman I, Bir C, Pickar D, Breier A. Neuroendocrinological impacts of glucoprivic stress Biological Psychiatry. 39: 645. DOI: 10.1016/0006-3223(96)84432-5 |
0.479 |
|
| 1996 |
Elman I, Wiesenfeld N, Su T, Malhotra A, Pickar D, Breier A. The effects of metabolic and cognitive stress on cerebral blood flow Biological Psychiatry. 39: 604-605. DOI: 10.1016/0006-3223(96)84299-5 |
0.489 |
|
| 1996 |
Breier A, Su T, Weisenfeld N, Elman I, Adler C, Malhotra A, Pickar D. Assessment of striatal dopamine function in schizophrenia Biological Psychiatry. 39: 513. DOI: 10.1016/0006-3223(96)83997-7 |
0.589 |
|
| 1995 |
Waltrip RW, Buchanan RW, Summerfelt A, Breier A, Carpenter WT, Bryant NL, Rubin SA, Carbone KM. Borna disease virus and schizophrenia. Psychiatry Research. 56: 33-44. PMID 7792340 DOI: 10.1016/0165-1781(94)02600-N |
0.313 |
|
| 1995 |
Carpenter WT, Conley RR, Buchanan RW, Breier A, Tamminga CA. Patient response and resource management: another view of clozapine treatment of schizophrenia. The American Journal of Psychiatry. 152: 827-32. PMID 7755110 DOI: 10.1176/Ajp.152.6.827 |
0.385 |
|
| 1995 |
Breier A. Serotonin, schizophrenia and antipsychotic drug action. Schizophrenia Research. 14: 187-202. PMID 7539288 DOI: 10.1016/0920-9964(94)00043-8 |
0.326 |
|
| 1995 |
Breier A. The management of treatment-resistant schizophrenia Current Opinion in Psychiatry. 8: 41-44. DOI: 10.1097/00001504-199501000-00010 |
0.377 |
|
| 1994 |
Breier A, Buchanan RW, Kirkpatrick B, Davis OR, Irish D, Summerfelt A, Carpenter WT. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. The American Journal of Psychiatry. 151: 20-6. PMID 8267129 DOI: 10.1176/Ajp.151.1.20 |
0.447 |
|
| 1994 |
Breier A, Buchanan RW, Waltrip RW, Listwak S, Holmes C, Goldstein DS. The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 10: 1-7. PMID 8179790 DOI: 10.1038/npp.1994.1 |
0.415 |
|
| 1994 |
Buchanan RW, Strauss ME, Kirkpatrick B, Holstein C, Breier A, Carpenter WT. Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Archives of General Psychiatry. 51: 804-11. PMID 7944870 DOI: 10.1001/archpsyc.1994.03950100052005 |
0.357 |
|
| 1994 |
Su T, Breier A, Malhotra A, Litman R, Hsiao J, Pickar D. Clozapine treatment in patients with chronic schizophrenia: efficacy and predictors of response Biological Psychiatry. 35: 745-746. DOI: 10.1016/0006-3223(94)91128-2 |
0.307 |
|
| 1993 |
Buchanan RW, Breier A, Kirkpatrick B, Elkashef A, Munson RC, Gellad F, Carpenter WT. Structural abnormalities in deficit and nondeficit schizophrenia. The American Journal of Psychiatry. 150: 59-65. PMID 8417581 DOI: 10.1176/Ajp.150.1.59 |
0.387 |
|
| 1993 |
Breier A, Davis OR, Buchanan RW, Moricle LA, Munson RC. Effects of metabolic perturbation on plasma homovanillic acid in schizophrenia. Relationship to prefrontal cortex volume. Archives of General Psychiatry. 50: 541-50. PMID 8317948 DOI: 10.1001/archpsyc.1993.01820190043005 |
0.424 |
|
| 1993 |
Breier A, Kirkpatrick B, Buchanan RW. Clozapine attenuates meta-chlorophenylpiperazine (mCPP)-induced plasma cortisol increases in schizophrenia. Biological Psychiatry. 34: 492-4. PMID 8268334 DOI: 10.1016/0006-3223(93)90241-5 |
0.427 |
|
| 1993 |
Wolkowitz OM, Coppola R, Breier A, Doran AR, Rubinow DR, Berrettini WH, Kling MA, Pickar D. Quantitative electroencephalographic correlates of steroid administration in man. Neuropsychobiology. 27: 224-30. PMID 8232843 DOI: 10.1159/000118985 |
0.31 |
|
| 1992 |
Albus M, Zahn TP, Breier A. Anxiogenic properties of yohimbine. I. Behavioral, physiological and biochemical measures. European Archives of Psychiatry and Clinical Neuroscience. 241: 337-44. PMID 1504110 DOI: 10.1007/BF02191958 |
0.304 |
|
| 1992 |
Kirkpatrick B, Carpenter WT, Maeda K, Buchanan RW, Breier A, Tamminga CA. Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatients. Biological Psychiatry. 32: 1049-54. PMID 1467385 DOI: 10.1016/0006-3223(92)90067-A |
0.358 |
|
| 1992 |
Breier A, Buchanan RW, Elkashef A, Munson RC, Kirkpatrick B, Gellad F. Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Archives of General Psychiatry. 49: 921-6. PMID 1449382 DOI: 10.1001/archpsyc.1992.01820120009003 |
0.372 |
|
| 1992 |
Breier A, Buchanan RW. The effects of metabolic stress on plasma progesterone in healthy volunteers and schizophrenic patients. Life Sciences. 51: 1527-34. PMID 1435061 DOI: 10.1016/0024-3205(92)90563-5 |
0.4 |
|
| 1992 |
Breier A, Schreiber JL, Dyer J, Pickar D. Course of illness and predictors of outcome in chronic schizophrenia: implications for pathophysiology. The British Journal of Psychiatry. Supplement. 38-43. PMID 1389040 DOI: 10.1192/S0007125000297031 |
0.38 |
|
| 1992 |
Breier A, Davis O, Buchanan R, Listwak SJ, Holmes C, Pickar D, Goldstein DS. Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humans. Biological Psychiatry. 32: 880-90. PMID 1334713 DOI: 10.1016/0006-3223(92)90177-2 |
0.348 |
|
| 1992 |
Breier A, Schreiber JL, Pickar D, Dyer J. Long-term Outcome in Chronic Schizophrenia-Reply Archives of General Psychiatry. 49: 503. DOI: 10.1001/Archpsyc.1992.01820060083016 |
0.387 |
|
| 1991 |
Breier A, Davis OR, Buchanan RW. Alprazolam attenuates metabolic stress-induced neuroendocrine and behavioral effects in humans. Psychopharmacology. 104: 479-84. PMID 1780418 DOI: 10.1007/BF02245653 |
0.343 |
|
| 1991 |
Breier A, Schreiber JL, Dyer J, Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. Archives of General Psychiatry. 48: 239-46. PMID 1671741 DOI: 10.1001/Archpsyc.1991.01810270051007 |
0.348 |
|
| 1991 |
Carpenter WT, Kurz R, Kirkpatrick B, Hanlon TE, Summerfelt AT, Buchanan RW, Waltrip RW, Breier A. Carbamazepine maintenance treatment in outpatient schizophrenics. Archives of General Psychiatry. 48: 69-72. PMID 1670617 DOI: 10.1001/Archpsyc.1991.01810250071010 |
0.319 |
|
| 1991 |
Davis O, Breier A, Buchanan R, Holstein C. Obstetric complications in schizophrenia Schizophrenia Research. 4: 254. DOI: 10.1016/0920-9964(91)90103-X |
0.397 |
|
| 1990 |
Breier A, Wolkowitz OM, Roy A, Potter WZ, Pickar D. Plasma norepinephrine in chronic schizophrenia. The American Journal of Psychiatry. 147: 1467-70. PMID 2221157 DOI: 10.1176/Ajp.147.11.1467 |
0.44 |
|
| 1990 |
Pickar D, Litman RE, Konicki PE, Wolkowitz OM, Breier A. Neurochemical and neural mechanisms of positive and negative symptoms in schizophrenia Modern Problems of Pharmacopsychiatry. 24: 124-151. PMID 1970851 DOI: 10.1159/000418015 |
0.447 |
|
| 1990 |
Schreiber JL, Breier A, Pickar D. Characteristics of patients selected for treatment on a schizophrenia research unit. Hospital & Community Psychiatry. 41: 441-3. PMID 1970550 DOI: 10.1176/Ps.41.4.441 |
0.352 |
|
| 1990 |
Pickar D, Breier A, Hsiao JK, Doran AR, Wolkowitz OM, Pato CN, Konicki PE, Potter WZ. Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia. Archives of General Psychiatry. 47: 641-8. PMID 1694425 DOI: 10.1001/Archpsyc.1990.01810190041006 |
0.396 |
|
| 1989 |
Wolkowitz OM, Doran A, Breier A, Roy A, Pickar D. Specificity of plasma HVA response to dexamethasone in psychotic depression Psychiatry Research. 29: 177-186. PMID 2798596 DOI: 10.1016/0165-1781(89)90032-2 |
0.342 |
|
| 1989 |
Doran AR, Rubinow DR, Wolkowitz OM, Roy A, Breier A, Pickar D. Fluphenazine treatment reduces CSF somatostatin in patients with schizophrenia: correlations with CSF HVA. Biological Psychiatry. 25: 431-9. PMID 2564787 DOI: 10.1016/0006-3223(89)90196-0 |
0.356 |
|
| 1989 |
Breier A. Experimental approaches to human stress research: Assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients Biological Psychiatry. 26: 438-462. PMID 2551397 DOI: 10.1016/0006-3223(89)90066-8 |
0.396 |
|
| 1989 |
WOLKOWITZ OM, BREIER A, DORAN A, LUCAS P, KELSOE J, PAUL SM, PICKAR D. Alprazolam Augmentation of Neuroleptics in Schizophrenia American Journal of Psychiatry. 146: 1087-a-1088. DOI: 10.1176/Ajp.146.8.1087-A |
0.303 |
|
| 1989 |
Wolkowitz O, Reus V, Breier A, Doran A, Pickar D. Alprazolam-neuroleptic treatment in schizophrenia Schizophrenia Research. 2: 215. DOI: 10.1016/0920-9964(89)90251-X |
0.409 |
|
| 1989 |
Harding C, Brooks G, Ashikaga T, Strauss J, Breier A. Long-term outcome of DSM-III schizophrenia Schizophrenia Research. 2: 27. DOI: 10.1016/0920-9964(89)90063-7 |
0.341 |
|
| 1989 |
Breier A. Alprazolam Augmentation of Antipsychotic Pharmacotherapy?-Reply Archives of General Psychiatry. 46: 1052. DOI: 10.1001/Archpsyc.1989.01810110094014 |
0.32 |
|
| 1988 |
Wolkowitz OM, Breier A, Doran A, Kelsoe J, Lucas P, Paul SM, Pickar D. Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary results. Archives of General Psychiatry. 45: 664-71. PMID 3289524 DOI: 10.1001/Archpsyc.1988.01800310072009 |
0.443 |
|
| 1988 |
Pickar D, Breier A, Kelsoe J. Plasma homovanillic acid as an index of central dopaminergic activity: studies in schizophrenic patients Annals of the New York Academy of Sciences. 537: 339-346. PMID 2904783 DOI: 10.1111/J.1749-6632.1988.Tb42118.X |
0.392 |
|
| 1988 |
Breier A, Wolkowitz OM, Doran AR, Bellar S, Pickar D. Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteers. Psychiatry Research. 25: 187-94. PMID 2845460 DOI: 10.1016/0165-1781(88)90050-9 |
0.359 |
|
| 1988 |
Charney DS, Price LH, Breier A. The Course of Panic Attacks and Agoraphobia-Reply Archives of General Psychiatry. 45: 502. DOI: 10.1001/Archpsyc.1988.01800290124016 |
0.313 |
|
| 1987 |
Pickar D, Wolkowitz OM, Labarca R, Doran AR, Breier A, Paul SM. Biochemical alterations produced by neuroleptics in man: studies of plasma homovanillic acid in schizophrenic patients. Psychopharmacology Series. 3: 248-54. PMID 3823092 DOI: 10.1007/978-3-642-71288-3_29 |
0.385 |
|
| 1987 |
Breier A, Wolkowitz OM, Doran AR, Roy A, Boronow J, Hommer DW, Pickar D. Neuroleptic responsivity of negative and positive symptoms in schizophrenia. The American Journal of Psychiatry. 144: 1549-55. PMID 3688278 DOI: 10.1176/Ajp.144.12.1549 |
0.374 |
|
| 1987 |
Pickar D, Wolkowitz OM, Doran AR, Labarca R, Roy A, Breier A, Narang PK. Clinical and biochemical effects of verapamil administration to schizophrenic patients. Archives of General Psychiatry. 44: 113-8. PMID 3545130 DOI: 10.1001/Archpsyc.1987.01800140015002 |
0.367 |
|
| 1987 |
Doran AR, Boronow J, Weinberger DR, Wolkowitz OM, Breier A, Pickar D. Structural brain pathology in schizophrenia revisited. Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acid. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 1: 25-32. PMID 3509912 DOI: 10.1016/0893-133X(87)90006-6 |
0.386 |
|
| 1987 |
Breier A, Arora PK, Wolkowitz OM, Pickar D, Paul SM. Metabolic Stress Produces Rapid Immunosuppression in Humans Archives of General Psychiatry. 44: 1108-1109. PMID 3500689 DOI: 10.1001/Archpsyc.1987.01800240084014 |
0.312 |
|
| 1987 |
Wolkowitz OM, Rubinow DR, Breier A, Doran AR, Davis C, Pickar D. Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatric illness. Life Sciences. 41: 1929-33. PMID 2889125 DOI: 10.1016/0024-3205(87)90745-4 |
0.32 |
|
| 1987 |
Pickar D, Roy A, Breier A, Doran A, Wolkowitz O, Colison J, Agren H. Suicide and aggression in schizophrenia. Neurobiologic correlates. Annals of the New York Academy of Sciences. 487: 189-96. PMID 2436533 DOI: 10.1111/j.1749-6632.1986.tb27898.x |
0.362 |
|
| 1986 |
Breier A, Charney DS, Heninger GR. Intravenous diazepam fails to change growth hormone and cortisol secretion in humans Psychiatry Research. 18: 293-299. PMID 3749390 DOI: 10.1016/0165-1781(86)90014-4 |
0.303 |
|
| 1986 |
Pickar D, Labarca R, Doran AR, Wolkowitz OM, Roy A, Breier A, Linnoila M, Paul SM. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment. Archives of General Psychiatry. 43: 669-76. PMID 3718170 DOI: 10.1001/Archpsyc.1986.01800070059008 |
0.412 |
|
| 1986 |
Doran AR, Breier A, Roy A. Differential diagnosis and diagnostic systems in schizophrenia. The Psychiatric Clinics of North America. 9: 17-33. PMID 3515329 |
0.306 |
|
| 1986 |
Wolkowitz OM, Doran AR, Breier A, Cohen MR, Pickar D. Endogenous opioid regulation of hypothalamo-pituitary-adrenal axis activity in schizophrenia. Biological Psychiatry. 21: 366-73. PMID 2869791 DOI: 10.1016/0006-3223(86)90164-2 |
0.306 |
|
| 1986 |
Wolkowitz OM, Pickar D, Doran AR, Breier A, Tarell J, Paul SM. Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia. The American Journal of Psychiatry. 143: 85-7. PMID 2867690 DOI: 10.1176/Ajp.143.1.85 |
0.3 |
|
| 1984 |
Charney DS, Heninger GR, Breier A. Noradrenergic Function in Panic Anxiety: Effects of Yohimbine in Healthy Subjects and Patients With Agoraphobia and Panic Disorder Archives of General Psychiatry. 41: 751-763. PMID 6742977 DOI: 10.1001/Archpsyc.1984.01790190025003 |
0.359 |
|
| Show low-probability matches. |